institute

MAJ INSTITUTE OF PHARMACOLOGY, POLISH ACADEMY OF SCIENCES

The Maj Institute of Pharmacology PAS, founded in 1954, is a premier Polish research institution recognized for its contributions to neuropharmacology, psychopharmacology, and biomedical sciences. Over the decades, it has expanded its research capabilities, leading to groundbreaking discoveries in drug mechanisms, neurological disorders, and innovative therapies.

Research & Academic Excellence

The Institute consists of 14 scientific departments, 6 laboratories, and multiple research units, specializing in psychopharmacology, neurobiology, neurochemistry, molecular neuroscience, pharmaceutical chemistry, and bioinformatics. It has full academic rights to confer PhD and DSc degrees in medical sciences, particularly in the field of medical biology.

The Institute employs 200 full-time staff, including 76 researchers (with 37 professors and associate professors), 72 technicians, and 52 administrative and support personnel. The Institute actively supports early-career scientists, with over 100 PhD students trained in recent years, many of whom have successfully defended their dissertations and continued careers in academia or the pharmaceutical industry.

The Institute’s scientists have published thousands of research papers, including high-impact original studies, and secured numerous patents. In recognition of its outstanding achievements, the Institute has been designated as a Centre of Excellence for Neuropharmacology and a Leading National Research Centre (KNOW).

Facilities & Scientific Impact

The Institute is equipped with four state-of-the-art laboratories for brain research, focusing on:

• Genomics
• Proteomics
• Cellular signaling
• Chemical synthesis

Thanks to major investments, the animal research facilities have been modernized to meet European Commission (EC) standards, ensuring ethical and high-quality research. The Institute is also an internationally recognized research institution with PHS Approved Animal Welfare Assurance (Assurance Number A5354-01).

Global Collaboration & Innovation

The Institute actively collaborates with leading research institutions worldwide, participating in European and international scientific programs. Its research has been funded by organizations such as the European Regional Development Fund, National Science Centre, and various international research grants. It plays a key role in translating scientific discoveries into clinical applications, contributing to new drug development and advanced therapeutic strategies.

For more information, visit IP PAS website.